MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Spiral Analysis Evaluates the Effects of Deep Brain Stimulation in Parkinson disease and Essential Tremor

    S. Radmard, S. Pullman (New York, NY, USA)

    Objective: To apply computerized spiral analysis to investigate upper limb kinematics and impact of deep brain stimulation (DBS) on motor dysfunction in Parkinson disease (PD) and…
  • 2019 International Congress

    Movement Disorders Spectrum in a Private Practice setup in India : A 7 Year Study

    P. Kukkle (Bangalore, India)

    Objective: To study the pattern and spectrum of Movement Disorders patients seen at a Private Movement Disorders Clinic in India Background: There is lack of…
  • 2019 International Congress

    Knowledge, Attitude and Practices about Movement Disorders in India

    B. Shetty, S. Mittal, P. Kukkle (Bangalore, India)

    Objective: To understand the Knowledge about various Movement Disorders (MD) in general public and in various Movement Disorder Patients subgroups Background: The incidence of movement…
  • 2019 International Congress

    The influence of deep brain stimulation on the Parkinson’s disease brain: functional improvement correlates with increased alpha2 and beta band functional connectivity

    L. Boon, W. Potters, A. Hillebrand, R. de Bie, M. Bot, R. Schuurman, C. Stam, F. van Rootselaar, H. Berendse (Amsterdam, Netherlands)

    Objective: To further unravel the mechanism of action of optimal deep brain stimulation (DBS) treatment effects in Parkinson’s disease (PD), by studying how DBS affects…
  • 2019 International Congress

    Strategies for Implementation of a Quality Improvement Registry for DBS in Parkinson’s Disease

    J. Jimenez-Shahed, P. D'Haese, J. Kirk, M. York, A. Berg, L. Shih, J. Schwalb, J. Mcinerney (Houston, TX, USA)

    Objective: To describe the implementation of a quality improvement (QI) patient registry for deep brain stimulation (DBS) in Parkinson's disease (PD). Background: QI projects are…
  • 2018 International Congress

    Safinamide in Parkinson’s disease

    G. Martí-Andrés, R. Jiménez-Bolaños, J. Arbelo-González, J. Pagonabarraga-Mora, C. Duran-Herrera, M. Carmona-Abellán, R. Luquin-Puido (Pamplona, Spain)

    Objective: To evaluate clinical effects, safety and tolerability of safinamide add-on levodopa in Parkinson’s disease (PD) patients. Background: Safinamide is a recently approved adjunctive treatment…
  • 2018 International Congress

    An evaluation of the availability and format of information provided to patients who have a new diagnosis of Parkinson’s disease (PD)

    L. Ebenezer, J. Price, H. Martin (Bridgend, United Kingdom)

    Objective: To evaluate if the information provided to a person with Parkinson’s (PwP) is relevant and appropriate for that individual. To also consider the need…
  • 2018 International Congress

    Superior cerebellar peduncles atrophy of PSP on PADRE imaging; comparison with idiopathic PD

    S. Kakeda, M. Miyata, T. Yoneda, S. Ide, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

    Objective: The purpose of our study was to determine whether atrophy of Superior cerebellar peduncles (SCP) on phase-weighted magnetic resonance imaging technique (PADRE) was useful…
  • 2018 International Congress

    A Phase 2A Study of Nilotinib in Patients with Advanced and Early Parkinson’s disease: Study Design

    T. Simuni, B. Fiske, K. Merchant, C. Coffey, H. Matthews, R. Wyse, P. Brundin, D. Simon, M. Schwarzschild, D. Weiner, C. Venuto, L. Trusso, L. Baker, M. Kostrzebski, T. Ward, G. Rafaloff (Chicago, IL, USA)

    Objective: To assess the safety and tolerability of nilotinib (150-300 mg QD) in moderate/advanced and early/de novo Parkinson disease (PD) participants. Background: Studies in cell…
  • 2018 International Congress

    The Interface of advanced therapies as Parkinson’s disease progresses – case reports

    C. Liang, S. Williams, L. Jones, C. Sue, P. Silberstein (St Leonards, Australia)

    Objective: To explore the practical benefits and challenges of adding duodenal levodopa-carbidopa intestinal gel infusion (LCIG) to subthalamic nucleus deep brain stimulation (STN DBS) in…
  • « Previous Page
  • 1
  • …
  • 233
  • 234
  • 235
  • 236
  • 237
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley